Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Evernow vs MEDVidi

Evernow
Graded #357

Higher grade

vs+0.7999999999999972
MEDVidi
Graded #384

Lower grade

The verdict

Evernow takes it — 58.8/100 to 58/100, but only just.

Evernow grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Evernow is a women's-focused, menopause-centered telehealth platform that prescribes branded GLP-1 weight loss medications including Ozempic, Wegovy, Zepbound, and Mounjaro via US-licensed clinicians. MEDVidi is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
45
45
Dose & formulationEven
53
53
Clinical oversightEvernow +6
83
77
Labs & monitoringMEDVidi +9
53
62
FulfillmentEvernow +8
67
59
Contract termsEven
55
55
Evernow · left barMEDVidi · right bar

The numbers

MetricEvernowMEDVidi
WeighScore58.8/10058/100
GradeCC
Scorecard rank#357#384
SemaglutideNot disclosedNot disclosed
TirzepatideNot disclosedNot disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessYesYes
Oral / sublingualInjection onlyInjection only
Evernow

Graded #357 · C

Strengths

  • Prescribes FDA-approved branded GLP-1s, not compounded
  • Accepts insurance for video visits (BCBS, Anthem, UnitedHealthcare, Aetna)
  • Integrates GLP-1 weight loss with menopause and HRT care
  • Flexible one-time visit or low-cost membership models

Where it loses points

  • Weight loss is one vertical alongside menopause and HRT care
  • GLP-1 medication cost depends on insurance and is not posted
  • State availability not specified on the site
MEDVidi

Graded #384 · C

Strengths

  • Licensed providers can prescribe brand-name Zepbound and Wegovy
  • Transparent flat consultation fees (195 dollar initial, 159 dollar follow-up)
  • Prescriptions sent to the patient's pharmacy of choice, so insurance can be used

Where it loses points

  • Consult-fee model: medication is not included and its cost is separate
  • No medication pricing is published
  • State list is shown as a map rather than enumerated

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard